Latest NS5 Stories
- Major regulatory milestone achieved toward approval in the European Union NORTH CHICAGO, Ill., Nov.
A study reveals how daclatasvir targets one of its proteins and causes the fastest viral decline ever seen with anti-HCV drugs – within 12 hours of treatment.
Hepatitis C virus (HCV) infection affects about 4 million in the United States and is the primary cause of liver cirrhosis and liver cancer.
- A poem in which the author retracts something said in an earlier poem.